179 related articles for article (PubMed ID: 17560456)
1. Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy.
Giordano A; Melina G; Calcagni ML; Schinzari F; Cirillo F; Mettimano M; Cardillo C; Melina D
Arch Med Res; 2007 Jul; 38(5):512-8. PubMed ID: 17560456
[TBL] [Abstract][Full Text] [Related]
2. Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy.
Kuwahara T; Hamada M; Hiwada K
J Nucl Med; 1998 Sep; 39(9):1486-91. PubMed ID: 9744329
[TBL] [Abstract][Full Text] [Related]
3. Use of [123I]MIBG to assess cardiac adrenergic innervation: experience in hypertensive cardiopathy and left ventricular aneurysms.
Giordano A; Calcagni ML; Rufini V; Colivicchi F; Melina D; Melina G; Pristipino C; Nori S; Trani C; Santarelli P
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):44-8. PubMed ID: 9002748
[TBL] [Abstract][Full Text] [Related]
4. [The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].
D'Alto M; Maurea S; Basso A; Varrella P; Polverino W; Bianchi U; Bonelli A; Salvatore M; Chiariello M
Cardiologia; 1998 Nov; 43(11):1231-6. PubMed ID: 9922590
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia.
Matsuo S; Takahashi M; Nakamura Y; Kinoshita M
J Nucl Med; 1996 May; 37(5):712-7. PubMed ID: 8965132
[TBL] [Abstract][Full Text] [Related]
6. Myocardial imaging with 123I-metaiodobenzylguanidine in essential hypertension and renovascular hypertension.
Ohya Y; Sasaki M; Fujishima S; Kagiyama S; Onaka U; Kaseda S; Ohmori S; Kuwabara Y; Abe I; Fujishima M
Clin Exp Hypertens; 2001 May; 23(4):293-304. PubMed ID: 11349821
[TBL] [Abstract][Full Text] [Related]
7. Cardiac sympathetic nervous system in early essential hypertension assessed by 123I-MIBG.
Sakata K; Shirotani M; Yoshida H; Kurata C
J Nucl Med; 1999 Jan; 40(1):6-11. PubMed ID: 9935049
[TBL] [Abstract][Full Text] [Related]
8. [Myocardial sympathetic activity and characteristics in hypertrophic cardiomyopathy: comparison with hypertensive hypertrophy].
Narita M; Kurihara T
J Cardiol; 1996 Mar; 27(3):133-41. PubMed ID: 8865685
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the relationship between regression of hypertensive cardiac hypertrophy and improvement of cardiac sympathetic nervous dysfunction using iodine-123 metaiodobenzylguanidine myocardial imaging.
Morimoto S; Terada K; Keira N; Satoda M; Inoue K; Tatsukawa H; Katoh S; Ida K; Sugihara H; Takeda K; Nakagawa M
Eur J Nucl Med; 1996 Jul; 23(7):756-61. PubMed ID: 8662113
[TBL] [Abstract][Full Text] [Related]
10. Use of iodine-123 metaiodobenzylguanidine scintigraphy to assess cardiac sympathetic denervation and the impact of hypertension in patients with non-insulin-dependent diabetes mellitus.
Tamura K; Utsunomiya K; Nakatani Y; Saika Y; Onishi S; Iwasaka T
Eur J Nucl Med; 1999 Oct; 26(10):1310-6. PubMed ID: 10541830
[TBL] [Abstract][Full Text] [Related]
11. Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease.
Mitrani RD; Klein LS; Miles WM; Hackett FK; Burt RW; Wellman HN; Zipes DP
J Am Coll Cardiol; 1993 Nov; 22(5):1344-53. PubMed ID: 8227790
[TBL] [Abstract][Full Text] [Related]
12. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
Langer A; Freeman MR; Josse RG; Armstrong PW
J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904
[TBL] [Abstract][Full Text] [Related]
13. [Isotopic study of myocardial perfusion and innervation in 28 patients with primary hypertrophic cardiomyopathy: relation to ventricular arrhythmia].
Casset-Senon D; Philippe L; Cosnay P; Lopez-Moutault J; Turot-Bracq V; Fauchier JP; Pottier JM
Arch Mal Coeur Vaiss; 1994 Apr; 87(4):475-83. PubMed ID: 7848036
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
Narita M; Kurihara T
J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388
[TBL] [Abstract][Full Text] [Related]
15. 123I-MIBG myocardial imaging in hypertensive patients: abnormality progresses with left ventricular hypertrophy.
Mitani I; Sumita S; Takahashi N; Ochiai H; Ishii M
Ann Nucl Med; 1996 Aug; 10(3):315-21. PubMed ID: 8883707
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
[TBL] [Abstract][Full Text] [Related]
17. [A case of hypertensive hypertrophy in which both regression of hypertrophy and improvement of the abnormalities in iodine-123-metaiodobenzylguanidine (MIBG) myocardial imagings were observed after antihypertensive therapy].
Morimoto S; Terada K; Keira N; Satoda M; Inoue K; Tatsukawa H; Katoh S; Sugihara H; Takeda K
Kaku Igaku; 1995 Oct; 32(10):1107-12. PubMed ID: 8523833
[TBL] [Abstract][Full Text] [Related]
18. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy.
Isobe S; Izawa H; Iwase M; Nanasato M; Nonokawa M; Ando A; Ohshima S; Nagata K; Kato K; Nishizawa T; Murohara T; Yokota M
J Nucl Med; 2005 Jun; 46(6):909-16. PubMed ID: 15937299
[TBL] [Abstract][Full Text] [Related]
19. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy.
Lanza GA; Giordano A; Pristipino C; Calcagni ML; Meduri G; Trani C; Franceschini R; Crea F; Troncone L; Maseri A
Circulation; 1997 Aug; 96(3):821-6. PubMed ID: 9264488
[TBL] [Abstract][Full Text] [Related]
20. Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.
Terai H; Shimizu M; Ino H; Yamaguchi M; Uchiyama K; Oe K; Nakajima K; Taki J; Kawano M; Mabuchi H
J Nucl Med; 2003 Oct; 44(10):1612-7. PubMed ID: 14530475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
